Archives

Presentations include preclinical data on Wee1/Myt1 inhibitor SGR-3515 and SOS1 inhibitor SGR-4174 NEW YORK, March 25, 2025--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that new...

• March 25, 2025 02:12 PM PDT
• EODHD

(Updating with additional details from the fourth paragraph onward) GFL Environmental (GFL.TO) af PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription...

• March 25, 2025 02:11 PM PDT
• EODHD

Tesla sales fall 47% in Europe in February, Trump Media will launch a series of ETFs with Crypto.com, and Oklo stock falls after the nuclear energy start-up reports a wider annual loss. Continue Readi...

• March 25, 2025 01:49 PM PDT
• EODHD

Bloomberg's Peter Elstrom discusses the growing number of Chinese AI models and what challenges that presents for US tech companies. He speaks with Caroline Hyde on "Bloomberg Technology." View Commen...

• March 25, 2025 01:48 PM PDT
• EODHD

BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients w...

• March 25, 2025 01:45 PM PDT
• EODHD

HOUSTON, March 25, 2025 (GLOBE NEWSWIRE) -- W&T Offshore, Inc. (NYSE: WTI) (“W&T” or the “Company”) today announced the promotion of Huan Gamblin to Executive Vice President and Chief Technical Office...

• March 25, 2025 01:45 PM PDT
• EODHD

Ripple Labs has settled with the US Securities and Exchange Commission (SEC). The company has agreed to pay a reduced $50 million fine in a case that has been closely watched by the cryptocurrency industry. The deal marks a major turning point for Ripple and its XRP token, as it effectively ends one of the […]

• March 25, 2025 01:40 PM PDT
• Invezz

- FHD-909 (LY4050784) advancing in an ongoing Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Oral presentation on preclinic...

• March 25, 2025 01:35 PM PDT
• EODHD

Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca will also present potential first-in-class examples of direct SMP complex in...

• March 25, 2025 01:31 PM PDT
• EODHD

WALTHAM, Mass. and BOULDER, Colo., March 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined...

• March 25, 2025 01:31 PM PDT
• EODHD